Low-sugar influenza vaccine and methods thereof

TW202639859APending Publication Date: 2026-10-01ROCK BIOMEDICAL INC
View PDF 0 Cites 0 Cited by

Patent Information

Application Number
TW114147543
Authority / Receiving Office
TW · TW
Patent Type
Applications
Current Assignee / Owner
Priority Date
2024-12-04
Filing Date
2025-12-04
Publication Date
2026-10-01

Smart Images

  • Figure TWG2TA001078670_001
    Figure TWG2TA001078670_001
  • Figure TWG2TA001078670_002
    Figure TWG2TA001078670_002
  • Figure TWG2TA001078670_003
    Figure TWG2TA001078670_003
Patent Text Reader

Abstract

The present disclosure relates to a low glycosylated influenza hemagglutinin (HA) protein and a vaccine designed to express the HA protein in vivo. The present disclosure also teaches a method for generating an immune response by utilizing the low glycosylated HA protein, which provides a broader protection across different influenza strains or lineages.
Need to check novelty before this filing date? Find Prior Art